Triglycerides + high-density-lipoprotein-cholesterol dyslipidaemia, a coronary risk factor in elderly women: The CArdiovascular STudy in the ELderly

Internal Medicine Journal

Volumn 35, Issue 10, 2005, Pages 604-610

  Mazza, Alberto ^a   Tikhonoff, V ^a   Schiavon, L ^a   Casiglia, E ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Coronary; Elderly; HDL cholesterol; Population; Risk; Triglycerides

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

AGED; ANTHROPOMETRY; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY RISK; DYSLIPIDEMIA; FEMALE; HUMAN; HUMAN TISSUE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL;

AGED; CHOLESTEROL, HDL; CONFIDENCE INTERVALS; CORONARY DISEASE; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTRIGLYCERIDEMIA; ITALY; POPULATION SURVEILLANCE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SURVIVAL RATE; TRIGLYCERIDES;

EID: 27644488742     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2005.00940.x     Document Type: Article

References (32)

1. De Backer G, Ambrosioni E, Borch-Johnsen K, Brotons C, Cifkova R, Dallongeville J et al. European guidelines on cardiovascular disease prevention in clinical practice: third joint task force of European and other societies on cardiovascular disease prevention in clinical practice. Atherosclerosis 2004; 173: 381-91.
2. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Educations Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-97.
3. Austin MA. Plasma triglycerides as a risk factor for coronary heart disease. The epidemiologic evidence and beyond. Am J Epidemiol 1989; 129: 249-59.
4. Criqui MH, Heiss G, Cohn R, Cowan LD, Suchindran CM, Bangdiwala S et al. Plasma triglycerides level and mortality from coronary heart disease. N Engl J Med 1993; 328: 1220-5.
5. Hokanson JE, Austin MA. Plasma triglycerides level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population prospective studies. J Cardiovasc Risk 1996; 3: 213-19.
6. Zimetbaum P, Frishman WH, Ooi LW, Derman MP, Aronson M, Gidez LI et al. Plasma lipids and lipoproteins and the incidence of cardiovascular disease in very elderly. The Bronx Aging Study. Arterioscler Thromb 1992; 12: 416-23.
7. Psaty BM, Anderson M, Kronmal R, Tracy RP, Orchard T, Fried LP et al. The association between lipid levels and the risk of incident myocardial infarction, stroke and total mortality: The Cardiovascular Health Study. J Am Geriatr Soc 2004; 52: 1639-47.
8. Jeppesen J, Hein HO, Suadicani P, Gyntelberg F. Triglyceride concentration and ischemic heart disease. An eight-year follow-up in the Copenhagen Males Study. Circulation 1998; 97: 1029-36.
9. Robins SJ, Collins D, Wittes JT, Papademetriou V, Deedwania PC, Schaefer EJ et al. Relation of gemfibrozil treatment and lipid levels with major coronary events: VA-HIT: a randomized controlled trial. JAMA 2001; 285: 1585-91.
10. The BIP Study Group. Secondary prevention by raising HDL cholesterol and reducing triglycerides in patients with artery disease: the Bezafibrate Infarction Prevention study. Circulation 2000; 102: 21-7.
11. Sheprhed J, Cobbe SM, Ford I, Isles CG, Lorimer AR, MacFarlane PW et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West Scotland Coronary Prevention Study Group. N Engl J Med 1995; 333: 1310-17.
12. Casiglia E, Palatini P. Cardiovascular risk factors in the elderly. J Hum Hypertens 1998; 12: 575-81.
13. Ledru F, Ducimetière P, Battaglia S, Courbon D, Beverelli F, Guize L et al. New diagnostic criteria for diabetes and coronary artery disease: insights from an angiographic study. J Am Coll Cardiol 2001; 37: 1543-50.
14. Patel A, Barzi F, Jamrozik K, Lam TH, Ueshima H, Whitlock G et al. Serum triglycerides as a risk factor for cardiovascular diseases in the Asia-Pacific Region. Circulation 2004; 110: 2678-86.
15. LaRosa JC. Triglycerides and coronary risk in women and the Elderly. Arch Intern Med 1997; 157: 961-8.
16. Assman G, Schulte H. Role of triglycerides in coronary artery disease: lessons from the Prospective Cardiovascular Munster Study. Am J Cardiol 1992; 8: 99-103.
17. Castelli WP. Epidemiology of triglycerides: a view from Framingham. Am J Cardiol 1992; 70: 3H-9H.
18. Manninen V, Tenkanen L, Koskinen P, Huttunen JK, Manttari M, Heinonen OP et al. Joint effects of serum triglycerides and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Circulation 1992; 85: 37-45.
19. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs. usual care: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. JAMA 2002; 288: 2998-3007.
20. Burchfiel CM, Laws A, Benfante R, Goldberg RJ, Hwang LJ, Chiu D et al. Combined effect of HDL cholesterol, triglycerides and total cholesterol concentration on 18-year risk of atherosclerotic disease. Circulation 1995; 92: 1430-6.
21. Szapary PO, Rader DJ. The triglycerides-high-density lipoprotein axis: an important target of therapy? Am Heart J 2004; 148: 211-21.
22. Lamarche B, Tchernof A, Moorjani S, Cantin B, Dagenais GR, Lupein P et al. Small, dense low density lipoprotein particles as a predictors of the risk of ischemic heart disease in men: prospective results from the Quebec Cardiovascular Study. Circulation 1997; 95: 69-75.
23. Yusuf S, Hawken S, Ôunpuu S, Dans T, Avezum A, Lanas F et al. Effects of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004; 364: 937-52.
24. Grundy SM, Brewer HB, Cleeman JI, Smith SC, Lenfant C. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related definition. Circulation 2004; 109: 433-8.
25. Jeppesen J, Hein HO, Suadicani P, Gyntelberg F. High triglycerides/low high-density lipoprotein cholesterol, ischemic electrocardiogram changes and risk of ischemic heart disease. Am Heart J 2003; 145: 103-8.
26. Huttunen JK, Heinonen OP, Manninen V, Koskinen P, Hakulinen T, Teppo L et al. The Helsinki Heart Study: an 8.5-year safety and mortality follow-up. J Intern Med 1994; 235: 31-9.
27. Heady JA, Morris JN, Oliver MF. WHO clofibrate/cholesterol trial: clarifications. Lancet 1992; 340: 1405-6.
28. Nielsen NE, Olsson AG, Swahn E. Plasma lipoprotein particle concentrations in postmenopausal women with unstable coronary artery disease. Analysis of diagnostic accuracy using receiver operating characteristics. J Intern Med 2000; 247: 43-52.
29. Lapidus L, Bengtsson C, Lindquist O, Sigurdsson JA, Rybo E. Triglycerides - main lipid risk factor for cardiovascular disease on women? Acta Med Scand 1985; 217: 481-9.
30. Simons LA, Friedlander Y, McCallum J, Simons J. Risk factors for coronary heart disease in the prospective Dubbo Study of Australian elderly. Atherosclerosis 1995; 117: 107-18.
31. LaRosa JC. Outcomes of lipid-lowering treatment in postmenopausal women. Drugs Aging 2002; 19: 595-604.
32. Menotti A, Kromhout D, Nissinen A, Giampaoli S, Seccareccia F, Feskens E et al. Short-term all-cause mortality and its determinants in elderly male population in Finland, The Netherlands and Italy: The FINE Study. Finland, Italy, Netherlands Elderly Study. Prev Med 1996; 25: 319-26.